Turning Point Therapeutics, Inc. (49) | Business Finance (8)

Browse by Subcategory

Recent Contracts

Underwriting Agreement, dated October 26, 2020, by and among Goldman Sachs & Co. LLC and SVB Leerink LLC, as representatives of the several underwriters named therein (Filed With SEC on October 27, 2020)
Description of Common Stock (Filed With SEC on March 18, 2020)
Fourth Amended and Restated Investor Rights Agreement, dated October 18, 2018, by and among the Registrant and certain of its securityholders (Filed With SEC on March 21, 2019)
Underwriting Agreement, dated May 18, 2020, by and among Goldman Sachs & Co. LLC and SVB Leerink LLC, as representatives of the several underwriters named therein (Filed With SEC on May 19, 2020)
Form of Underwriting Agreement (Filed With SEC on September 3, 2019)
Form of Underwriting Agreement (Filed With SEC on April 8, 2019)
Form of Common Stock Certificate of the Registrant (Filed With SEC on April 8, 2019)
Turning Point Therapeutics, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on April 8, 2019)